Modica, Roberta
 Distribuzione geografica
Continente #
NA - Nord America 924
EU - Europa 410
AS - Asia 287
AF - Africa 38
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.662
Nazione #
US - Stati Uniti d'America 918
IT - Italia 210
SG - Singapore 186
CN - Cina 75
NL - Olanda 70
CI - Costa d'Avorio 37
DE - Germania 30
FI - Finlandia 21
UA - Ucraina 17
SE - Svezia 16
IE - Irlanda 14
VN - Vietnam 13
GB - Regno Unito 11
FR - Francia 10
CA - Canada 6
IN - India 6
HK - Hong Kong 4
CZ - Repubblica Ceca 3
ES - Italia 2
PL - Polonia 2
AR - Argentina 1
BD - Bangladesh 1
CH - Svizzera 1
EU - Europa 1
JP - Giappone 1
MD - Moldavia 1
NP - Nepal 1
PE - Perù 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 1.662
Città #
Chandler 185
Singapore 153
Ashburn 125
Santa Clara 72
Amsterdam 66
Naples 63
Millbury 23
Beijing 21
Des Moines 20
Napoli 19
Milan 18
Seattle 18
Boston 15
Jacksonville 15
Lawrence 15
Nanjing 14
Rome 14
Princeton 13
Dong Ket 12
Washington 12
Helsinki 11
Wilmington 11
Munich 10
Portici 9
Kronberg 8
Nanchang 7
Houston 6
Lappeenranta 5
Los Angeles 5
Ottawa 5
Paris 5
Buffalo 4
Dublin 4
Hong Kong 4
Pune 4
Boardman 3
Brno 3
Casavatore 3
Hebei 3
London 3
Philadelphia 3
Woodbridge 3
A Coruña 2
Ann Arbor 2
Bari 2
Bicester 2
Cagliari 2
Chongqing 2
Dallas 2
Fairfield 2
Frankfurt am Main 2
Marcianise 2
Messina 2
Mosciano Sant'Angelo 2
Piano Di Sorrento 2
Pozzuoli 2
Redwood City 2
Riva del Garda 2
Scafati 2
Shenyang 2
Shenzhen 2
Solaro 2
Tappahannock 2
Torre Del Greco 2
West Jordan 2
Afragola 1
Arienzo 1
Atlanta 1
Bassersdorf 1
Brindisi 1
Brusciano 1
Buenos Aires 1
Chisinau 1
Council Bluffs 1
Dhaka 1
Edinburgh 1
Forest City 1
Freiburg im Breisgau 1
Garden City 1
Giugliano In Campania 1
Guangzhou 1
Hangzhou 1
Hanoi 1
Jiaxing 1
Johannesburg 1
Kagoya 1
Kathmandu 1
Kunming 1
Köln 1
Landshut 1
Lembach 1
Lima 1
Marzano di Nola 1
Mcallen 1
Mumbai 1
New Delhi 1
Norwich 1
Nuremberg 1
Palermo 1
Portland 1
Totale 1.093
Nome #
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication. 62
Hepatic arterial embolization in patients with neuroendocrine tumors. 60
GLP-1: benefits beyond pancreas. 58
Quality of Life in Patients with Neuroendocrine Neoplasms: The Role of Severity, Clinical Heterogeneity and Resilience 52
Pituitary function and morphology in Fabry disease. 49
Emerging therapies in pheochromocytoma and paraganglioma: Immune checkpoint inhibitors in the starting blocks 45
Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis 44
Diagnosis of Flier’s syndrome in a patient with nondiabetic hypoglycemia: a case report and critical appraisal of the literature 43
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 43
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib 42
The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept study 41
Nutrition and neuroendocrine tumors: An update of the literature. 41
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? 41
Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives 40
Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors 39
Chronotype: what role in the context of gastroenteropancreatic neuroendocrine tumors? 38
Efficacy and Safety of Everolimus in Extrapancreatic Neuroendocrine Tumor: A Comprehensive Review of Literature 37
Open issues on G3 neuroendocrine neoplasms: Back to the future 37
Bone metastases in neuroendocrine neoplasms: From pathogenesis to clinical management 36
An incidental rectal neuroendocrine microcarcinoma ('micro-NEC') coexistent with a high grade adenoma 36
Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors <2 cm 35
Pancreatic Neuroendocrine Tumors in patients with Multiple Endocrine Neoplasia Type 1: Diagnostic Value of Different MRI Sequences 35
The safety of available treatments options for neuroendocrine tumors 34
Therapeutic sequences in patients with grade 1−2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group 34
Immune checkpoint blockade for Merkel cell carcinoma: actual findings and unanswered questions 34
Complete clinical and biochemical control with cabergoline and octreotide in a patient with ectopic ACTH syndrome before surgery 29
Erratum to: GLP-1: Benefits beyond pancreas 26
Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies (Oct, 10.1007/s40618-022-01905-4, 2022) 25
ASO Visual Abstract: Radical Resection in Enteropancreatic Neuroendocrine Tumors-Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 23
Health-related quality of life in patients with neuroendocrine neoplasms: a two-wave longitudinal study 21
Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors 21
Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumors 21
Role of Metformin on Recurrence-Free Survival in Neuroendocrine Tumors 20
Therapeutic strategies for patients with neuroendocrine neoplasms: current perspectives 20
Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target 20
A rare rarity: Neuroendocrine tumor of the esophagus 19
A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in Italy 16
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 15
Characterization of Atypical Pheochromocytomas with Correlative MRI and Planar/Hybrid Radionuclide Imaging: A Preliminary Study 15
Radical Resection in Entero-Pancreatic Neuroendocrine Tumors: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 14
What Lies behind Paraneoplastic Hypercalcemia Secondary to Well-Differentiated Neuroendocrine Neoplasms? A Systematic Review of the Literature 14
Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches 14
Calcium-stimulated calcitonin test for the diagnosis of medullary thyroid cancer: results of a multicenter study and comparison between different assays 13
Nonconventional Doses of Somatostatin Analogs in Patients with Progressing Well-Differentiated Neuroendocrine Tumor 13
Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study 13
Prognostic significance of laterality in lung neuroendocrine tumors 13
Interventional cytopathologist can successfully combine ultrasonographical and microscopic skills to narrow the differential diagnosis in fine‐needle aspiration of neck paraganglioma 13
Risk factors for gastroenteropancreatic neuroendocrine neoplasms ({GEP}-{NENs}): a three-centric case{\textendash}control study 13
Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers 13
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus 13
Vitamin D and Bone Metabolism in Adult Patients with Neurofibromatosis Type 1 13
PRRT: identikit of the perfect patient 12
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) 12
Recurrence-Free Survival in Early and Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung after Complete Tumor Resection 12
Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms 11
MR imaging characterization of pheochromocytoma: a comparison between typical and atypical tumor lesions 11
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 11
Corrigendum to: Quality of Life in Patients with Neuroendocrine Neoplasms: The Role of Severity, Clinical Heterogeneity, and Resilience (vol 106, pg e316, 2020) 11
Natural History and Management of Familial Paraganglioma Syndrome Type 1: Long-Term Data from a Large Family 11
Parathyroid diseases and metabolic syndrome 10
Laryngeal Neuroendocrine Tumor With Elevated Serum Calcitonin: A Diagnostic and Therapeutic Challenge. Case Report and Review of Literature 10
Carcinoma showing thymus-like differentiation (CASTLE): a case report 10
Gastrinomas and non-functioning pancreatic endocrine tumors in multiple endocrine neoplasia syndrome type-1 (MEN-1) 10
No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus 9
Current understanding of pathogenetic mechanisms in neuroendocrine neoplasms 9
Clinical presentation and recurrence of pituitary neuroendocrine tumors: results from a single referral center in Colombia 9
Endocrine-disrupting chemicals (EDCs) and cancer: new perspectives on an old relationship 9
Bone metabolism and vitamin D implication in gastroenteropancreatic neuroendocrine tumors 8
Targeting neuroendocrine tumors with octreotide and lanreotide: Key points for clinical practice from NET specialists 8
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 8
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons 7
Autoimmune polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) in Sicily: Confirmation that R203X is the peculiar AIRE gene mutation 7
Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials? 6
A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial 6
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study 6
Thyroid transcription factor‐1 expression in lung neuroendocrine tumours: a gender-related biomarker? 6
Neuroendocrine Tumors and Immune System 6
Evaluation of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Systemic Immune–Inflammation Index (SII) as Potential Biomarkers in Patients with Sporadic Medullary Thyroid Cancer (MTC) 6
Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells? 5
Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead 5
Sunitinib nei feocromocitomi e paragangliomi 4
Neuroendocrine Neoplasms 4
Gestione integrata del tumore della prostata: il ruolo dell’endocrinologo 3
Authorship of Italian medical literature on neuroendocrine neoplasms: any gender gap? 3
Telling science and Innovation. Rare plat net 3
null 3
Immune checkpoint inhibitors in cancer therapy: The leading role of the endocrinologist 3
Nuove strategie terapeutiche per il trattamento dei NET 3
Endocrine Pathology 3
Carcinoide timico in paziente affetta da sindrome da neoplasie endocrine multiple di tipo 1 (MEN1): ruolo dello screening radiologico e medico-nucleare 2
Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study 2
Selpercatinib e carcinoma midollare della tiroide 2
Recent advances and future challenges in the diagnosis of neuroendocrine neoplasms 2
Metastasi ossee nei tumori neuroendocrini: presentazione clinica e terapia 2
Gender Differences in Lung Neuroendocrine Tumors: A Single-Center Experience 1
Editorial: Neuroendocrine tumors: the road to precision medicine 1
Totale 1.798
Categoria #
all - tutte 11.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.636


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202041 0 0 0 0 6 3 0 2 1 13 12 4
2020/202191 0 5 16 10 9 13 9 1 7 2 6 13
2021/2022215 2 0 25 3 5 14 1 6 17 16 64 62
2022/2023494 31 57 14 39 51 41 54 33 50 81 41 2
2023/2024515 20 66 53 48 40 67 17 84 3 16 69 32
2024/2025339 108 83 25 34 89 0 0 0 0 0 0 0
Totale 1.798